Literature DB >> 2104225

IL 3 and IL 6 do not induce bone resorption in vitro.

B E Barton1, R Mayer.   

Abstract

Bone resorption in vitro and in vivo can be induced by interleukin 1 (IL 1) and tumor necrosis factor (TNF), both of which are potent inflammatory cytokines. Additionally, there are other factors produced by cells which can active osteoclasts. Because diverse factors are involved in bone resorption, we examined the role of two other inflammatory cytokines, IL 3 and IL 6. IL 3 has been shown to induce the formation of osteoclast-like cells from precursors, while IL 6 is a potent mediator of inflammatory responses. Osteoclast activity in neonatal mouse calvaria was measured as 45Ca released into the supernatant fluid following a 48 hr incubation period with cytokine. Our results show that while parathyroid hormone (PTH) and IL 1 are potent inducers of bone resorption, neither IL 3 nor IL 6 displayed such activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104225     DOI: 10.1016/1043-4666(90)90019-p

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.

Authors:  G Lisignoli; A Piacentini; S Toneguzzi; F Grassi; B Cocchini; A Ferruzzi; G Gualtieri; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice.

Authors:  J Dai; D Lin; J Zhang; P Habib; P Smith; J Murtha; Z Fu; Z Yao; Y Qi; E T Keller
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells.

Authors:  J Green; S Schotland; Z Sella; C R Kleeman
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

4.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones.

Authors:  I Holt; M W Davie; I P Braidman; M J Marshall
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

6.  Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation.

Authors:  Michael Darowish; Ra'Kerry Rahman; Ping Li; Susan V Bukata; Jill Gelinas; Willis Huang; Lisa M Flick; Edward M Schwarz; Regis J O'Keefe
Journal:  Bone       Date:  2009-06-12       Impact factor: 4.398

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.